CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares traded.
CardioGenics Trading Down 100.0 %
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Further Reading
- Five stocks we like better than CardioGenics
- Consumer Staples Stocks, Explained
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are Dividend Champions? How to Invest in the Champions
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
